In melanoma, the probiotic Lactobacillus reuteri releases I3A, activating AhR in CD8+ T cells to produce IFN‐γ, enhancing immune checkpoint inhibitor efficacy and prolonging progression‐free survival (PFS) and overall survival (OS) [222]. The gene discussed is AHR; the disease is melanoma.